Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

02 October 2008

Effects of cruciferous allyl nitrile on phase 2 antioxidant and detoxification enzymes

Hideji TaniiABCDEG, Tomomi HigashiABC, Fusae NishimuraBCF, Yoshihiro HiguchiABE, Kiyofumi SaijohABE

Med Sci Monit 2008; 14(10): BR189-192 :: ID: 869404

Abstract

Background
High intake of cruciferous vegetables has been associated with lower risk of various cancers, and the cancer preventive effect of the vegetables has been associated with their high levels of glucosinolates. The hydrolysis of glucosinolates results in the generation of bioactive compounds, including allyl nitrile which we previously found to be an active inducer of some phase 2 enzymes. In this study, we further explored the inductive ability of this nitrile in light of increasing evidence that antioxidants delay or prevent the development of cancer.
Material and Method
Groups of 6 mice were administered subtoxic doses of allyl nitrile (5, 50, 100 or 200 micromol/kg) or vehicle-distilled water daily for 5 days by gastric intubation. On the sixth day, the animals were sacrificed for examination of enzyme activities in their tissues. Enzymes tested were thioredoxin reductase (TR), glutathione peroxidase (GPx), glutathione reductase (GR) and catalase.
Results
Allyl nitrile increased the activity of TR in the liver, kidneys and rectum at doses of 100-200 micromol/kg/day, and GPx in the kidneys and small intestine at 50 to 200 micromol/kg/day, while in the colon, alone, it decreased the activities of GR and catalase at doses of 200 and 100-200 micromol/kg/day, respectively not.
Conclusions
The present results suggest an involvement of allyl nitrile in antioxidant defense in the body, except for the colon.

Keywords: Thioredoxin-Disulfide Reductase - metabolism, Nitriles - pharmacology, Glutathione Reductase - metabolism, Metabolic Detoxication, Drug, Glutathione Peroxidase - metabolism, Glucosinolates - metabolism, Catalase - metabolism, Tissue Distribution, Brassicaceae - chemistry, Antioxidants - metabolism

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750